Some studies describe the association of various laboratory parameters with cardiovascular comorbidity in dialysis patients: C-reactive protein and plasma fibrinogen [8,9], as well as the presence of metabolic syndrome [10]. This evidence concerns the gene CRP and metabolic syndrome.